Veuillez noter que la page demandée n’est pas disponible dans la langue par défaut sélectionnée. Vous utilisez notre plateforme dans une autre langue maintenant.
This statistic shows the consolidated net profit of the French pharmaceutical group Ipsen from 2014 to 2018, in million euros. It appears that this figure has been increasing over the years, reaching almost 400 million euros in 2018. In 2019, the group's consolidated net profit reached a low of 50.2 million euros.
Consolidated net profit of the French pharmaceutical group Ipsen from 2014 to 2019 (in million euros)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Total liabilities of the Ipsen group 2014-2019
- Premium Statistic Research and development expenditure of the Ipsen group 2014-2019
- Premium Statistic Total assets of the Ipsen group 2014-2019
- Premium Statistic Total equity of the Ipsen group 2014-2019
- Premium Statistic Operating profit of the Ipsen group 2014-2019
- Premium Statistic Global revenue in general medicine of the Ipsen group 2014-2019
- Premium Statistic Commercial expenses of the Ipsen group 2014-2019
- Premium Statistic Global revenue in specialty medicine of the Ipsen group 2014-2019
- Premium Statistic Global revenue of the Ipsen group 2019, by geographical area
- Basic Statistic Top drugs based on projected 2024 global sales
About the region
10
- Basic Statistic Members of EFPIA's pharmaceutical exports and imports 1990-2022
- Premium Statistic Members of EFPIA's pharmaceutical market value 2000-2022
- Basic Statistic Medication sales of the Ipsen Group 2019
- Premium Statistic Global revenue of the Ipsen group 2014-2019
- Basic Statistic Ipsen group sales 2019, by therapeutic area
- Basic Statistic Allocation of R&D investments in pharmaceutical industry by function 2021
- Basic Statistic Orphan drug sales worldwide by therapy category 2028
- Basic Statistic Orphan vs. non-orphan pipeline sales forecast worldwide 2023-2028
- Premium Statistic Top global companies by orphan drug revenues 2023
- Basic Statistic Merck & Co total assets 2009-2023
Selected statistics
6
- Premium Statistic Expenditure worldwide on diabetes by market 2013-2018
- Premium Statistic Medicinal market growth worldwide including rebates 2009-2018
- Basic Statistic AstraZeneca's revenue from top product Pulmicort 2006-2023
- Premium Statistic Standard Unit medicine use per capita in the U.S. 2007-2011
- Premium Statistic Chinese insulin market distribution: leading companies 2011
- Premium Statistic U.S. insulin market distribution: leading companies 2011
Other regions
10
- Basic Statistic Members of EFPIA's pharmaceutical production value 1990-2022
- Premium Statistic Operating profit of JW Pharmaceutical 2014-2022
- Premium Statistic Revenue from pharmaceutical manufacturer in Denmark 2009-2023
- Premium Statistic Number of orphan designations accepted in the U.S. 2003-2023
- Premium Statistic R&D expense revenue share of selected Chinese pharma companies 2021-2022
- Premium Statistic Sold packaging units of phytopharmaceuticals in Germany in 2022, by sales channel
- Premium Statistic Leading orphan designations in the EU by indication 2015
- Premium Statistic Mexico: pharmaceutical production 2017-2022
- Premium Statistic Venezuela: pharma industry market value 2008-2017
- Premium Statistic Value added of pharmaceutical companies in Italy 2016-2018
Related statistics
10
- Basic Statistic Number of employees of pharmaceutical companies by region France 2020
- Premium Statistic Revenue of the top ten pharmaceutical companies in France 2021
- Basic Statistic Total revenue of the French drug market worldwide 2010-2018
- Premium Statistic Number of companies in the pharmaceutical industry in France 1970-2018
- Basic Statistic Breakdown of employees of drug companies by age France 2014
- Premium Statistic Net investments of Boiron laboratories 2014-2022
- Premium Statistic Global turnover of Boiron's specialties segment 2022, by region
- Premium Statistic Average full-time equivalent workforce of Boiron Laboratories 2012-2022
- Premium Statistic Cashflow of Boiron laboratories 2013-2022
- Premium Statistic Boiron's stock price at the end of the year 2012-2022
Further related statistics
10
- Merck & Co - expenditure on research and development 2006-2023
- M&A capacities - changes for the global pharma industry 2008-2015
- Merck & Co cash dividends declared 2006-2023
- Celgene's revenue and net income 2006-2018
- Sanofi's total assets 2007-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- Sales of Johnson & Johnson 2006-2023 by region
- Revenue of Sinopharm 2011-2022, by category
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Global pharmaceutical pipeline by therapy area 2013-2017
Further Content: You might find this interesting as well
Statistics
- Merck & Co - expenditure on research and development 2006-2023
- M&A capacities - changes for the global pharma industry 2008-2015
- Merck & Co cash dividends declared 2006-2023
- Celgene's revenue and net income 2006-2018
- Sanofi's total assets 2007-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- Sales of Johnson & Johnson 2006-2023 by region
- Revenue of Sinopharm 2011-2022, by category
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Global pharmaceutical pipeline by therapy area 2013-2017
Ipsen. (February 13, 2020). Consolidated net profit of the French pharmaceutical group Ipsen from 2014 to 2019 (in million euros) [Graph]. In Statista. Retrieved May 11, 2024, from https://www.statista.com/statistics/1072959/ipsen-consolidated-net-profit-french-company/
Ipsen. "Consolidated net profit of the French pharmaceutical group Ipsen from 2014 to 2019 (in million euros)." Chart. February 13, 2020. Statista. Accessed May 11, 2024. https://www.statista.com/statistics/1072959/ipsen-consolidated-net-profit-french-company/
Ipsen. (2020). Consolidated net profit of the French pharmaceutical group Ipsen from 2014 to 2019 (in million euros). Statista. Statista Inc.. Accessed: May 11, 2024. https://www.statista.com/statistics/1072959/ipsen-consolidated-net-profit-french-company/
Ipsen. "Consolidated Net Profit of The French Pharmaceutical Group Ipsen from 2014 to 2019 (in Million Euros)." Statista, Statista Inc., 13 Feb 2020, https://www.statista.com/statistics/1072959/ipsen-consolidated-net-profit-french-company/
Ipsen, Consolidated net profit of the French pharmaceutical group Ipsen from 2014 to 2019 (in million euros) Statista, https://www.statista.com/statistics/1072959/ipsen-consolidated-net-profit-french-company/ (last visited May 11, 2024)
Consolidated net profit of the French pharmaceutical group Ipsen from 2014 to 2019 (in million euros) [Graph], Ipsen, February 13, 2020. [Online]. Available: https://www.statista.com/statistics/1072959/ipsen-consolidated-net-profit-french-company/